Please assess the completion status of the following clinical trial:

Trial Title: Medtronic Concomitant Utilization of Radio Frequency for Atrial Fibrillation CURE-AF/Persistent

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Patients must have a documented history of persistent AF as defined by the ACC/AHA/ESC Guidelines: Characterized as episodes of non-self-terminating atrial fibrillation that usually lasts more than 7 days.~2. Concomitant indication (other than AF) for open-heart surgery for one or more of the following:~   * Mitral valve repair or replacement~  * Aortic valve repair or replacement~  * Tricuspid valve repair or replacement~  * Atrial septal defect (ASD) repair~  * Patent foramen ovale (PFO) closure~  * Coronary artery bypass procedures~3. Greater than or equal to 18 years of age~4. Able and willing to comply with study requirements by signing a consent form~5. Must be able to take the anticoagulant warfarin (Coumadin)~Exclusion Criteria:~1. Wolff-Parkinson-White syndrome~2. NYHA Class = IV~3. Left ventricular ejection fraction ≤ 30%~4. Need for emergent cardiac surgery (i.e. cardiogenic shock)~5. Previous atrial ablation for AF, AV-nodal ablation, or surgical Maze procedure~6. Contraindication for anticoagulation therapy~7. Left atrial diameter \> 7.0 cm~8. Preoperative need for an intra-aortic balloon pump or intravenous inotropes~9. Renal failure requiring dialysis or hepatic failure~10. Life expectancy of less than one year~11. Pregnancy or desire to be pregnant within 12 months of the study treatment.~12. Current diagnosis of active systemic infection~13. Documented MI 6 weeks prior to study enrollment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).